Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01746355
Other study ID # RG-01
Secondary ID
Status Completed
Phase N/A
First received November 27, 2012
Last updated April 24, 2014
Start date March 2011
Est. completion date January 2014

Study information

Verified date April 2014
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

Atypical Facial Pain is a chronic condition and presents controversies during diagnostic and treatment, between specialist not have consensus about the pathophysiology. It is possible consider this entitie a potential neuropathic cause without pathological signs. It knows the repetitive transcranial magnetic presents good results in the treatment of chronic pain coditions. The aim this study is evaluated the thresholds and excitability cortical in patients with AFP and verify the patterns of improvement in pain for patients undergoing rTMS compared to controls, as well as the therapeutic response to neuromodulation procedures. This enroll 20 patients with DAF and 20 controls treated with rTMS (5 sessions) and evaluated through questionnaires (EDOF clinical record, McGill Pain Questionnaire, Visual Analogue Scale, Inventory of symptoms of neuropathic pain, neuropathic pain DN4 questionnaire, SF -36, brief pain inventory). At the end of the data will be statistically analyzed and expressed as mean and standard deviation, and analyzed by Student's t test, analysis of variance (ANOVA), Tukey-Kramer and Pearson correlation. The level of significance is 5%. The results will be published in journals indexed in the area both nationally and internationally and presented at conferences and scientific meetings.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 2014
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Fulfill criteria of Atypical Facial Pain by International Headache Society

- Signed Term of Informed Consent

Exclusion Criteria:

- Trauma of Skull, epilepsy don't treated,

- Use of medications decrease the seizure threshold

- Patients in use of drugs, how cocaine and alcohol

- neurosurgical clips, pacemakers, increased intracranial pressure (risk of sequelae after seizure)

- Pregnant or lacting women

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
rTMS
Patients undergoing of repetitive transcranial magnetic stimulation for treatment of AFP.

Locations

Country Name City State
Brazil Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP) São Paulo SP

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Baselin of Pain Assessing by verbal analog scale (VAS) base line (moment of inclusion) and end of each session rTMS (4X in three months) No
Secondary Excitability cortical Changes in the measure of excitability cortical baseline (in the moment of inclusion) and end of each session of rTMS (4X in three months) No